EVOX THERAPEUTICS Trademark

Trademark Overview

On Thursday, December 15, 2016, a trademark application was filed for EVOX THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the EVOX THERAPEUTICS trademark a serial number of 79209128. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Tuesday, April 5, 2022. This trademark is owned by Evox Therapeutics Limited. The EVOX THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; biological preparations comprising exosome for medical use; biological reagents comprising exosome for medical use; mixed biological preparations comprising exosome for pharmaceutical and medical use; diagnostic reagents comprising exosome for medicinal use in the fields of biology, genetic engineering and pharmaceuticals; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in the detection of infectious diseases, cancer, diabetes, obesity, metabolic syndrome, dementia, mitochondrial disease, neuromuscular disease, inflammatory diseases and autoimmune disorders

Scientific, medical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; biological research; clinical research in the field of transformational therapeutics; providing medical and scientific research information in the field of filtration of exosomes from blood; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of infectious diseases and metabolic disorders; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science

General Information

Serial Number79209128
Word MarkEVOX THERAPEUTICS
Filing DateThursday, December 15, 2016
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateTuesday, April 5, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesDrug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; biological preparations comprising exosome for medical use; biological reagents comprising exosome for medical use; mixed biological preparations comprising exosome for pharmaceutical and medical use; diagnostic reagents comprising exosome for medicinal use in the fields of biology, genetic engineering and pharmaceuticals; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in the detection of infectious diseases, cancer, diabetes, obesity, metabolic syndrome, dementia, mitochondrial disease, neuromuscular disease, inflammatory diseases and autoimmune disorders
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesScientific, medical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; biological research; clinical research in the field of transformational therapeutics; providing medical and scientific research information in the field of filtration of exosomes from blood; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of infectious diseases and metabolic disorders; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 6, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 6, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEvox Therapeutics Limited
Party Type11 - New Owner Before Publication
Legal Entity Type98 - Unknown
AddressGB
Party NameEvox Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Thursday, June 1, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, June 6, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 6, 2017ASSIGNED TO EXAMINER
Saturday, June 10, 2017APPLICATION FILING RECEIPT MAILED
Monday, June 12, 2017NON-FINAL ACTION WRITTEN
Tuesday, June 13, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 20, 2017REFUSAL PROCESSED BY MPU
Tuesday, June 20, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, July 8, 2017REFUSAL PROCESSED BY IB
Wednesday, December 13, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 13, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 15, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 15, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 16, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 10, 2018FINAL REFUSAL WRITTEN
Wednesday, January 10, 2018FINAL REFUSAL E-MAILED
Wednesday, January 10, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, February 15, 2018CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, June 27, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, June 27, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 27, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 20, 2018SUSPENSION LETTER WRITTEN
Friday, July 20, 2018LETTER OF SUSPENSION E-MAILED
Friday, July 20, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, November 7, 2018NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, November 7, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, November 23, 2018NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, February 6, 2019ASSIGNED TO LIE
Wednesday, February 6, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, August 6, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, February 10, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, July 30, 2020NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, August 19, 2020SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, September 10, 2020NON-FINAL ACTION WRITTEN
Thursday, September 10, 2020NON-FINAL ACTION E-MAILED
Thursday, September 10, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 9, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 9, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 9, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 9, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 9, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, March 9, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 9, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 9, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 19, 2021SUBSEQUENT FINAL REFUSAL WRITTEN
Monday, April 19, 2021SUBSEQUENT FINAL EMAILED
Monday, April 19, 2021NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Tuesday, October 19, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, October 20, 2021EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, October 20, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, October 20, 2021EX PARTE APPEAL-INSTITUTED
Monday, October 25, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 25, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, December 4, 2021NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, December 8, 2021ACTION CONTINUING FINAL - COMPLETED
Wednesday, December 8, 2021ACTION DENYING REQ FOR RECON E-MAILED
Wednesday, December 8, 2021NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Tuesday, February 22, 2022EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Tuesday, April 5, 2022EXPARTE APPEAL TERMINATED
Tuesday, April 5, 2022ABANDONMENT - AFTER EX PARTE APPEAL
Tuesday, April 5, 2022ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Tuesday, April 5, 2022ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Wednesday, April 5, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, April 5, 2023FINAL DISPOSITION NOTICE SENT TO IB
Monday, April 24, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, November 25, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB

Related Keywords

therapeutics evox research medical pharmaceutical services development biological comprising exosome preparations scientific